Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
-
Oracle Enhances Electronic Data Capture Solution to Streamline Clinical Trials and Help Bring New Therapies to Market Faster
-
PrimeVigilance Enhances Efficiency and Patient Safety with Oracle Argus Platform
-
New Updates in Oracle Life Sciences Empirica Streamline Safety Signal Management Compliance in the Cloud
-
Oracle (ORCL) PT Raised to $176 at Argus, Remains on Focus List
-
Oracle Advances Safety Case Management for Life Science Organizations
-
Oracle (ORCL) PT Raised to $159 at Argus
-
Oracle (ORCL) now seen as a buy at Argus
-
Argus Upgrades Oracle (ORCL) to Buy
-
United BioSource, LLC Selects Oracle Cloud Safety Technology for its Safety Programs
-
Today's most important upgrades
-
Today's Most Important Upgrades
-
Servier Selects Oracle to Unify its Clinical Trial Operations
-
Global Contract Research Organisation Expands Services with Oracle Argus Cloud
-
Pharmas Turn to Oracle to Meet New Drug Safety Reporting Regulations in China
-
KCR Streamlines Drug Safety Reporting with Oracle
-
More Than 60% of Drug Safety Experts Plan To Use AI to Improve the Speed and Security of Adverse Event Case Processing
-
Oracle Argus Supports E2B(R3) Exchange with the European Medicines Agency's Enhanced EudraVigilance System
-
Celltrion taps Oracle Health Sciences Safety Solutions to Help Bring Cost-Effective Life-Saving and Biosimilar Drugs to Market
-
UPDATE: Argus Upgrades Oracle (ORCL) to Buy
-
Oracle Delivers Complete Cloud Solution to Help Pharma Companies Improve Drug Safety
-
Oracle Health Sciences Adds 93 Emerging Biopharmaceutical Customers
-
Oracle Expands Clinical Safety Monitoring and Reporting Capabilities With Oracle Argus 8.0 Solutions
-
Argus Downgrades Oracle (ORCL) to Hold
-
Daily State of the Markets: A Fistful of Reasons
-
Notable Analyst Rating Changes 06/04: JOYG, MRK, ORCL, SGMS Upgraded; INFA, HYC, NLC, STP Downgraded
-
Notable Analyst Rating Changes 02/01: BIDU, ALV, G, ARG, ASH Upgraded; CPF, M, LZ, COGT, WCRX Downgraded
-
David Moenning's Daily State of the Markets: 6/8
-
Notable Analyst Rating Changes 5/27: RF, PFG, LVS, SLP Upgraded; CTXS, BIG, CTCM Downgraded

